First Clinical Medical College, Jinan University, Tianhe, Guangzhou, Guangdong 510632, P.R. China.
Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.
Mol Med Rep. 2022 Apr;25(4). doi: 10.3892/mmr.2022.12664. Epub 2022 Mar 2.
A large number of studies have reported that microRNA (miR)‑374c‑5p plays an important role in the occurrence and development of malignant tumors, but there is no research on the role of miR‑374c‑5p in hepatocellular carcinoma (HCC). The aim of the present study was to investigate the role of miR‑374c‑5p in HCC and the underlying molecular mechanism. The expression of miR‑374c‑5p in HCC tissues and HCC cell lines was analyzed via reverse transcription‑quantitative PCR. The association between miR‑374c‑5p and clinical pathology was also analyzed in patients with HCC. Kaplan‑Meier analysis and Cox multivariate analysis were used to evaluate the prognostic significance of miR‑374c‑5p in HCC. The biological functions of miR‑374c‑5p, including cell proliferation, migration and invasion and its potential molecular mechanism were analyzed and . In addition, the molecular mechanism of miR‑374c‑5p in HCC was further explored. The results demonstrated that miR‑374c‑5p expression was lower in HCC than in matched adjacent tissue samples. Patients with low expression of miR‑374c‑5p had poor prognosis and short survival time. Overexpression of miR‑374c‑5p inhibited HCC cell proliferation, migration and invasion . , it was found that overexpression of miR‑374c‑5p significantly inhibited the growth and proliferation of HCC cells. Dual‑luciferase reporter assays verified that miR‑374c‑5p directly targets the 3'‑untranslated region of pituitary tumor‑transforming 1 (PTTG1) and regulates PTTG1 expression. In general, it was revealed that miR‑374c‑5p regulates the malignant biological behavior of HCC through PTTG1, thereby affecting epithelial‑mesenchymal transition. Thus, miR‑374c‑5p is a potential biological indicator to predict poor prognosis in patients with HCC.
大量研究报道,微小 RNA(miR)-374c-5p 在恶性肿瘤的发生和发展中发挥重要作用,但 miR-374c-5p 在肝细胞癌(HCC)中的作用尚缺乏相关研究。本研究旨在探讨 miR-374c-5p 在 HCC 中的作用及其潜在的分子机制。通过逆转录-定量 PCR 分析 HCC 组织和 HCC 细胞系中 miR-374c-5p 的表达。还分析了 HCC 患者 miR-374c-5p 与临床病理的相关性。Kaplan-Meier 分析和 Cox 多因素分析用于评估 miR-374c-5p 在 HCC 中的预后意义。分析 miR-374c-5p 的生物学功能,包括细胞增殖、迁移和侵袭,以及其潜在的分子机制。此外,还进一步探讨了 miR-374c-5p 在 HCC 中的分子机制。结果表明,miR-374c-5p 在 HCC 中的表达低于匹配的相邻组织样本。miR-374c-5p 低表达的患者预后不良,生存时间短。过表达 miR-374c-5p 抑制 HCC 细胞增殖、迁移和侵袭。此外,还发现过表达 miR-374c-5p 可显著抑制 HCC 细胞的生长和增殖。双荧光素酶报告基因检测证实,miR-374c-5p 可直接靶向垂体瘤转化蛋白 1(PTTG1)的 3'非翻译区,并调节 PTTG1 的表达。总的来说,研究结果表明,miR-374c-5p 通过 PTTG1 调节 HCC 的恶性生物学行为,从而影响上皮-间充质转化。因此,miR-374c-5p 是预测 HCC 患者不良预后的潜在生物学指标。